Correlation
The correlation between UE and GSK is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
UE vs. GSK
Compare and contrast key facts about Urban Edge Properties (UE) and GlaxoSmithKline plc (GSK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: UE or GSK.
Performance
UE vs. GSK - Performance Comparison
Loading data...
Key characteristics
UE:
0.38
GSK:
-0.10
UE:
0.77
GSK:
0.03
UE:
1.10
GSK:
1.00
UE:
0.36
GSK:
-0.11
UE:
0.92
GSK:
-0.21
UE:
11.74%
GSK:
14.94%
UE:
24.85%
GSK:
27.40%
UE:
-71.78%
GSK:
-54.70%
UE:
-21.65%
GSK:
-6.43%
Fundamentals
UE:
$2.47B
GSK:
$83.20B
UE:
$0.65
GSK:
$2.06
UE:
27.94
GSK:
19.92
UE:
6.59
GSK:
0.40
UE:
5.44
GSK:
2.64
UE:
1.80
GSK:
4.35
UE:
$453.51M
GSK:
$31.53B
UE:
$261.70M
GSK:
$22.56B
UE:
$274.75M
GSK:
$8.24B
Returns By Period
In the year-to-date period, UE achieves a -14.65% return, which is significantly lower than GSK's 24.07% return. Over the past 10 years, UE has underperformed GSK with an annualized return of 2.08%, while GSK has yielded a comparatively higher 7.42% annualized return.
UE
-14.65%
-0.82%
-19.64%
6.13%
2.72%
17.72%
2.08%
GSK
24.07%
7.11%
22.94%
-4.31%
8.97%
9.00%
7.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
UE vs. GSK — Risk-Adjusted Performance Rank
UE
GSK
UE vs. GSK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Urban Edge Properties (UE) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
UE vs. GSK - Dividend Comparison
UE's dividend yield for the trailing twelve months is around 3.85%, less than GSK's 3.94% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
UE Urban Edge Properties | 3.85% | 3.16% | 3.50% | 4.54% | 3.16% | 5.26% | 4.59% | 5.29% | 3.45% | 2.98% | 3.41% | 0.00% |
GSK GlaxoSmithKline plc | 3.94% | 4.65% | 3.75% | 4.78% | 6.17% | 6.86% | 5.34% | 6.95% | 7.13% | 8.84% | 7.44% | 7.60% |
Drawdowns
UE vs. GSK - Drawdown Comparison
The maximum UE drawdown since its inception was -71.78%, which is greater than GSK's maximum drawdown of -54.70%. Use the drawdown chart below to compare losses from any high point for UE and GSK.
Loading data...
Volatility
UE vs. GSK - Volatility Comparison
The current volatility for Urban Edge Properties (UE) is 7.89%, while GlaxoSmithKline plc (GSK) has a volatility of 8.47%. This indicates that UE experiences smaller price fluctuations and is considered to be less risky than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
UE vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between Urban Edge Properties and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UE vs. GSK - Profitability Comparison
UE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Urban Edge Properties reported a gross profit of 79.08M and revenue of 118.17M. Therefore, the gross margin over that period was 66.9%.
GSK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, GlaxoSmithKline plc reported a gross profit of 5.58B and revenue of 7.52B. Therefore, the gross margin over that period was 74.2%.
UE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Urban Edge Properties reported an operating income of 28.98M and revenue of 118.17M, resulting in an operating margin of 24.5%.
GSK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, GlaxoSmithKline plc reported an operating income of 2.22B and revenue of 7.52B, resulting in an operating margin of 29.5%.
UE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Urban Edge Properties reported a net income of 8.20M and revenue of 118.17M, resulting in a net margin of 6.9%.
GSK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, GlaxoSmithKline plc reported a net income of 1.62B and revenue of 7.52B, resulting in a net margin of 21.6%.